ロード中...
Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors
Hemophilia patients with inhibitors faced the constraint of inadequate treatment for several years before the era of recombinant factor VIIa (rFVII). Initially, rFVIIa was used in the compassionate-use programs. After a worldwide license was issued, more than 1.5 million doses were administered. Ble...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2010
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3262327/ https://ncbi.nlm.nih.gov/pubmed/22282682 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|